• FR
  • EN
  • JP
  • News
  • Careers
  • Contact Us
Menu

Oncodesign innovation vector.

Oncodesign
  • About
  • Offerings
  • Innovation model
  • Technologies
  • Investors
 

News

  • News
  • Upcoming events
  • Webinars
  • Scientific publications
    • Papers
      • Papers 2012-2017
      • Papers 2006-2011
      • Papers 2002-2005
      • Papers 1999-2001
      • Papers 1995-1998
      • Papers 1988-1994
    • Posters
      • Posters & Presentations 2020
      • Posters & Presentations 2019
      • Posters & Presentations 2018
      • Posters 2017
      • Posters 2016
      • Posters 2015
      • Posters 2014
      • Posters 2013
      • Posters 2012
      • Posters 2011
      • Posters 2010
      • Posters 2009
      • Posters 2008
      • Posters 2007
      • Posters 2006
      • Posters 2004-2005
      • Posters 2000-2003
  1. Home
  2. News
  3. [Congress] 8th Antibody Industrial Symposium, November 23-24, 2020

Tweets by OncodesignSA

[Congress] 8th Antibody Industrial Symposium, November 23-24, 2020

[Congress] 8th Antibody Industrial Symposium, November 23-24, 2020

The digital edition 2020 will focus on the following scientific theme: "Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases". The event will include plenary lectures, a session dedicated to presenting the latest advances in the field and talks by pharmaceutical companies and manufacturers based in France and abroad.

On this occasion, our scientists will be able to present our offer in Bioanalysis (BAL, LC-MS/MS and q-PCR) performed in compliance with GLP (Good Laboratory Practices). 
In addition, we also propse you an offering related to biopharmaceuticals which will be highlighted during the poster session.

[ POSTER] [EN] mAb formulation development and stability studies through complementary and orthogonal analytical methods

I read it!

[POSTER] [EN] Development of an immunogenicity assay for Anti-Drug Antibody (ADA) detection directed against an oligonucleotide CpG-D35 using ECL technology (MSD)

I read it!

Join us on the partnering platform to exchange with our experts!

Cécile Olivarius, Céline Guigue & Karine Mouchain will be connected to give you the answers you need for your project. 

Schedule a meeting with Cécile

I want to know more!

About Oncodesign
  • Vision
  • Our mission
  • Key figures
  • Management
  • Scientific Advisory Board
  • Where to find us
Offerings
  • Services
  • Partnerships 
  • Licensing
  • Therapeutic areas & Experimental models
Our innovation model
  • Etiology
  • Discovery
  • Experimentation
Our technologies
  • Nanocyclix®
  • T.O.T.
  • PREDICT®
  • Chi-mice®
  • Pharmimage®
  • OncoSNIPE®
Investors
  • A word from the Chairman
  • Financial calendar
  • Shares
  • Documentation
  • Sign up for email alerts
  • Investors contacts
Carreers
  • Our values
  • Job offers/work-study arrangements
  • Internships
  • Spontaneous applications
News
  • Upcoming events
  • Webinars
  • Scientific publications
Contact
  • Contact us
  • Sales team
logo AFSII
logo AAALAC

Personal Data PolicyLegal noticeContact Us

(C) copyright Oncodesign - all right reserved

20 rue Jean Mazen | B.P. 27627 | 21076 Dijon Cedex | France | Tel.+33 (0)3.80.78.82.60 | Fax +33 (0)3.80.78.82.61

Newsletter- en

Subscribe to the general newsletter

Invalid Input

Invalid Input

Invalid Input

Subscribe to the Investor Alert

Oncodesign